GOSS Stock Analysis: Buy, Sell, or Hold?
GOSS - Gossamer Bio, Inc. Common Stock
$0.14
-0.03 (-15.09%)
▼
5d:
-26.06%
30d:
-7.63%
90d:
-64.81%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Get Alerted When GOSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GOSS this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GOSS is down 26.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GOSS is down 26.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GOSS is currently trading at $0.14, which is considered oversold relative to its 30-day fair value range of $0.16 to $0.18.
Technical Outlook: Technically, GOSS is in a strong uptrend. The price is currently testing key support at $0.15. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 15.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.86 (+2575.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GOSS is in a strong uptrend. The price is currently testing key support at $0.15. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 15.1% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.86 (+2575.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.16 -
$0.18
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding GOSS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-15.1%)
- BULLISH: Trading 2575.9% below Wall St target ($3.86)
- WARNING: Recommendation downgraded due to -26.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.16 -
$0.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.15
Resistance Level
$0.20
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.56
Wall Street Target
$3.86
(+2575.9%)
Revenue Growth (YoY)
71.5%
Share & Embed Analysis
Last updated: July 14, 2026 3:51 AM ET
Data refreshes hourly during market hours. Next update: 4:51 AM
Data refreshes hourly during market hours. Next update: 4:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
Advanced GOSS Option Strategies
Professional options setups generated by AI based on today's GOSS price and gamma walls.
